| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.53 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |